Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11241425 Composition for treating mental illness

Patent 11241425 was granted and assigned to Alkermes (company) on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 10 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11951111 Immediate release multilayer tablet
0
Edits on 13 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Article (+403 characters)
Article

Patent abstract

The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.

Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707466 Immediate release multilayer tablet
0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1124142500
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alkermes (company)
Alkermes (company)
0
Current Assignee
Alkermes (company)
Alkermes (company)
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112414250
Date of Patent
February 8, 2022
0
Patent Application Number
170712360
Date Filed
October 15, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112414250
Patent Citations
‌
US Patent 10112903 Heterocyclic compounds for the treatment of neurological and psychological disorders
0
‌
US Patent 10231963 Methods for treating depressive symptoms
0
‌
US Patent 10287250 Morphan and morphinan analogues, and methods of use
0
‌
US Patent 10300054 Methods for treating antipsychotic-induced weight gain
0
‌
US Patent 10716785 Methods for treating antipsychotic-induced weight gain
0
‌
US Patent 10736890 Methods for treating depressive symptoms
0
‌
US Patent 10752592 Morphan and morphinan analogues, and methods of use
0
‌
US Patent 10822306 Heterocyclic compounds for the treatment of neurological and psychological disorders
0
Patent Primary Examiner
‌
Jason Deck
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alkermes (company)
Alkermes (company)
0
Current Assignee
Alkermes (company)
Alkermes (company)
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112414250
Date of Patent
February 8, 2022
0
Patent Application Number
170712360
Date Filed
October 15, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112414250
Patent Citations
‌
US Patent 10112903 Heterocyclic compounds for the treatment of neurological and psychological disorders
0
‌
US Patent 10231963 Methods for treating depressive symptoms
0
‌
US Patent 10287250 Morphan and morphinan analogues, and methods of use
0
‌
US Patent 10300054 Methods for treating antipsychotic-induced weight gain
0
‌
US Patent 10716785 Methods for treating antipsychotic-induced weight gain
0
‌
US Patent 10736890 Methods for treating depressive symptoms
0
‌
US Patent 10752592 Morphan and morphinan analogues, and methods of use
0
‌
US Patent 10822306 Heterocyclic compounds for the treatment of neurological and psychological disorders
0
Patent Primary Examiner
‌
Jason Deck
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11241425
Edits on 9 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Feb, 2022
Edits made to:
Infobox (+17 properties)
‌

 US Patent 11241425 Composition for treating mental illness

Infobox
Is a
Patent
Patent
Patent applicant
Alkermes (company)
Alkermes (company)
Current assignee
Alkermes (company)
Alkermes (company)
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11241425
Date of patent
February 8, 2022
Patent application number
17071236
Date Filed
October 15, 2020
Patent citations
‌
US Patent 10112903 Heterocyclic compounds for the treatment of neurological and psychological disorders
‌
US Patent 10231963 Methods for treating depressive symptoms
‌
US Patent 10287250 Morphan and morphinan analogues, and methods of use
‌
US Patent 10300054 Methods for treating antipsychotic-induced weight gain
‌
US Patent 10716785 Methods for treating antipsychotic-induced weight gain
‌
US Patent 10736890 Methods for treating depressive symptoms
‌
US Patent 10752592 Morphan and morphinan analogues, and methods of use
‌
US Patent 10822306 Heterocyclic compounds for the treatment of neurological and psychological disorders
Patent primary examiner
‌
Jason Deck

Find more entities like US Patent 11241425 Composition for treating mental illness

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo